GH logo

GH
Guardant Health Inc

4,904
Mkt Cap
$11.49B
Volume
1.11M
52W High
$120.74
52W Low
$36.36
PE Ratio
-26.43
GH Fundamentals
Price
$87.60
Prev Close
$87.08
Open
$87.66
50D MA
$89.18
Beta
1.39
Avg. Volume
2.2M
EPS (Annual)
-$3.32
P/B
-115.23
Rev/Employee
$391,867.92
$13,314.24
Loading...
Loading...
News
all
press releases
Short Interest in Guardant Health, Inc. (NASDAQ:GH) Decreases By 15.0%
Guardant Health, Inc. (NASDAQ:GH - Get Free Report) was the recipient of a significant decline in short interest in the month of April. As of April 15th, there was short interest totaling 11,642,109 shares, a decline of 15.0% from the March 31st total of 13,696,676 shares. Based on an average...
MarketBeat·2d ago
News Placeholder
More News
News Placeholder
Guardant Health, Inc. $GH Shares Sold by Mitsubishi UFJ Trust & Banking Corp
Mitsubishi UFJ Trust & Banking Corp cut its holdings in shares of Guardant Health, Inc. (NASDAQ:GH - Free Report) by 18.2% in the fourth quarter, according to its most recent filing with the...
MarketBeat·3d ago
News Placeholder
Delta Investment Management LLC Buys Shares of 22,236 Guardant Health, Inc. $GH
Delta Investment Management LLC purchased a new position in Guardant Health, Inc. (NASDAQ:GH - Free Report) during the fourth quarter, according to the company in its most recent disclosure with the...
MarketBeat·3d ago
News Placeholder
Guardant Health Inks Multi-Year Oncology Deal With Nuvalent
(RTTNews) - Thursday, Guardant Health, Inc. (GH) announced a multi-year strategic collaboration with Nuvalent, Inc. (NUVL) to support the development and potential commercialization of the latter's...
Nasdaq News: Markets·3d ago
News Placeholder
Guardant Health (GH) May Report Negative Earnings: Know the Trend Ahead of Next Week's Release
Guardant Health (GH) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Zacks·3d ago
News Placeholder
Guardant Health, Inc. $GH Position Trimmed by Jennison Associates LLC
Jennison Associates LLC decreased its holdings in shares of Guardant Health, Inc. (NASDAQ:GH - Free Report) by 20.5% in the 4th quarter, according to the company in its most recent disclosure with...
MarketBeat·3d ago
News Placeholder
Guardant Health Announces Multi-Year Strategic Collaboration with Nuvalent to Develop Companion Diagnostics and Support Potential Commercialization of Targeted Cancer Therapies Using the Guardant Infinity Platform
Guardant Health, Inc. (Nasdaq: GH), a leading precision oncology company, today announced a multi-year strategic collaboration with Nuvalent, Inc. (Nasdaq: NUVL), a clinical-stage biopharmaceutical...
Business Wire·3d ago
News Placeholder
Guardant Health, Inc. (NASDAQ:GH) Given Average Rating of "Moderate Buy" by Analysts
Guardant Health, Inc. (NASDAQ:GH - Get Free Report) has been assigned an average recommendation of "Moderate Buy" from the twenty-two analysts that are covering the company, MarketBeat.com reports...
MarketBeat·4d ago
News Placeholder
Guardant Health (GH) to Release Earnings on Thursday
Guardant Health (NASDAQ:GH) will be releasing its Q1 2026 earnings after the market closes on Thursday, May 7. (View Earnings Report at https://www.marketbeat.com/earnings/reports/2026-5-7-guardant-health-inc-stock...
MarketBeat·4d ago
News Placeholder
Guardant Health to Participate in Upcoming Investor Conferences
Guardant Health, Inc. (Nasdaq: GH), a leading precision oncology company, today announced the company will be participating in the following investor conferences. BofA Securities 2026 Healthcare...
Business Wire·4d ago
<
1
2
...
>

Latest GH News

View
Top Discussions

Advertisement|Remove ads.

Advertisement|Remove ads.